Silverarc Capital Management »

Cogent Biosciences shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Cogent Biosciences shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.2M 360k 14.36

More positions owned by Silverarc Capital Management

Abivax Sa Sponsored Ads (ABVX)
Rhythm Pharmaceuticals (RYTM)
Avidity Biosciences Ord (RNA)
Nuvalent Inc-a (NUVL)
Urogen Pharma (URGN)
Akero Therapeutics (AKRO)
Insmed Com Par $.01 (INSM)
Dianthus Therapeutics (DNTH)
Uniqure Nv SHS (QURE)
Cg Oncology (CGON)
United Therapeutics Corp Del Put Put Option
Oric Pharmaceuticals (ORIC)
Cidara Therapeutics Com New (CDTX)
Fractyl Health (GUTS)
Kalvista Pharmaceuticals (KALV)

View all positions for Silverarc Capital Management

Top funds holding Cogent Biosciences

Silverarc Capital Management
Exome Asset Management
Simplex Trading
Group One Trading

View all funds holding Cogent Biosciences